Dr. Agarwal's Eye Hospital Ltd. operates as an eye hospital, which engages in the provision of eye care solutions. Its services include operations in cataract, cornea lasik and smile, retina, orbit and oculoplasty, optical, glaucoma, uvea, neuro ophthalmology, and squint and pediatric ophthalmology. It also conducts continuous training and research and development programs. The company was founded in 1957 by Jaiveer Agarwal, Tahira Agarwal, Amar Agarwal, and Athiya Agarwal and is headquartered in Chennai, India.

Dr. Agarwal's Eye Hospital Limited

SERI Lugano is involved in research and innovation in vision, focusing on advanced ophthalmic treatments and therapies for various eye conditions.

SERI Lugano

Dr. Agarwals Eye Hospital operates in the healthcare sector providing eye care services, including treatments for various eye diseases.

Metric
Company Name	Dr. Agarwal's Eye Hospital Limited	SERI Lugano
Symbol	DRAGARWQ
MSH ID	COM:DRAGARWAL	CH:SERI-LUGANO
Market	STOCKS	PRIVATE
Sector	Healthcare	Healthcare & Health Services
Industry	Medical - Care Facilities	Medical & Healthcare
Country	IN	CH
Stage
Employee Count	974
Website	dragarwal.com	seri-lugano.ch
LinkedIn		seri-lugano
Founders

Metric
Market Cap	182.55M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	37.70M
Revenue (LTM)
Revenue (NTM)
Gross Profit	12.99M
EBITDA	10.75M
Operating Income	7.61M
Net Income	5.47M
EPS	1.16
Diluted EPS	1.16
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.77
Operating Profit Margin	0.21
EBITDA Margin	0.29
Net Profit Margin	0.15
Return on Equity	0.76
Return on Assets	0.10
Return on Capital Employed	0.16

DRAG

COM:DRAGARWAL

Dr. Agarwals Eye Hospital

Last Close

4,974.30

25/11 09:21

Market Cap

15.46B

Beta: -

Volume Today

557

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	30.93
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	7.66
EV Multiple	23.22

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding	33.83
Operating Cycle	48.69
Cash Conversion Cycle
Asset Turnover	0.69

Metric
Operating Cash Flow	10.68M
Free Cash Flow	2.26M
Cash Flow to Debt	0.73
Operating Cash Flow/Sales	0.15
Free Cash Flow Yield	0.03

Metric
Cash & Equivalents	3.98M
Accounts Receivable	-438.01K
Inventory	1.15M
Goodwill	21.25K
Debt to Capitalization	0.29
Debt to Assets
Current Ratio
Quick Ratio	0.62

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue	0.16